BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu S, Bennett RG, Kharbanda KK, Harrison-Findik DD. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol 2016; 8(4): 211-225 [PMID: 26855692 DOI: 10.4254/wjh.v8.i4.211]
URL: https://www.wjgnet.com/1007-9327/full/v8/i4/211.htm
Number Citing Articles
1
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn Callaway, Clint Cheng, Martha E Hensel, Rani Menon, Robert C Alaniz, Kyongbum Lee, Arul Jayaraman. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in miceeLife 2024; 12 doi: 10.7554/eLife.87458
2
Sara Ahmadi Badi, Ahmad Bereimipour, Pejman Rohani, Shohreh Khatami, Seyed Davar Siadat. Interplay between gut microbiota and the master iron regulator, hepcidin, in the pathogenesis of liver fibrosisPathogens and Disease 2024; 82 doi: 10.1093/femspd/ftae005
3
Sathish Kumar Natarajan, Bailey A. Stringham, Ashley M. Mohr, Cody J. Wehrkamp, Sizhao Lu, Mary Anne Phillippi, Dee Harrison-Findik, Justin L. Mott. FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosisJournal of Lipid Research 2017; 58(5): 866 doi: 10.1194/jlr.M071357
4
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn Callaway, Clint Cheng, Martha E Hensel, Rani Menon, Robert C Alaniz, Kyongbum Lee, Arul Jayaraman. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in miceeLife 2024; 12 doi: 10.7554/eLife.87458.3
5
Shanmugam Murugaiha Jeyakumar, Ayyalasomayajula Vajreswari. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidenceWorld Journal of Hepatology 2022; 14(1): 168-179 doi: 10.4254/wjh.v14.i1.168
6
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical markerMolecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7
7
Aleksandra A Kolodziejczyk, Danping Zheng, Oren Shibolet, Eran Elinav. The role of the microbiome in NAFLD and NASH EMBO Molecular Medicine 2019; 11(2) doi: 10.15252/emmm.201809302
8
Meilin Zhu, Hanqing Chen, Shuang Zhou, Lingna Zheng, Xue Li, Runxuan Chu, Wei Chen, Bing Wang, Meng Wang, Zhifang Chai, Weiyue Feng. Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overloadNanotoxicology 2021; 15(6): 761 doi: 10.1080/17435390.2021.1919329
9
Mete Ucdal, Ayse Burus, Basak Celtikci, Hatice Yasemin Balaban. A novel brick on the wall of non-alcoholic fatty liver disease (NAFLD): Nuclear receptor coactivator 4 (NCOA4)Medical Hypotheses 2023; 181: 111203 doi: 10.1016/j.mehy.2023.111203
10
Han Chen, Ying-Yi Li, Kouki Nio, Hong Tang. Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic PotentialBiomolecules 2024; 14(8): 1013 doi: 10.3390/biom14081013
11
Hui Chen, Wenshan Zhao, Xuzhen Yan, Tao Huang, Aiting Yang. Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic SteatohepatitisJournal of Clinical and Translational Hepatology 2022; 10(4): 577 doi: 10.14218/JCTH.2021.00289
12
Jing Liu, Bingbing Sun, Huijun Yin, Sijin Liu. HepcidinMedicine 2016; 95(14): e3150 doi: 10.1097/MD.0000000000003150
13
Philipp Bernhardt, Wolfgang Kratzer, Julian Schmidberger, Tilmann Graeter, Beate Gruener. Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosisBMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3212-1
14
Marie-Luise Bouvier, Karin Fehsel, Andrea Schmitt, Eva Meisenzahl-Lechner, Wolfgang Gaebel, Martina von Wilmsdorff. Sex-dependent effects of long-term clozapine or haloperidol medication on red blood cells and liver iron metabolism in Sprague Dawley rats as a model of metabolic syndromeBMC Pharmacology and Toxicology 2022; 23(1) doi: 10.1186/s40360-021-00544-4
15
Alicia R. Folgueras, Sandra Freitas-Rodríguez, Andrew J. Ramsay, Cecilia Garabaya, Francisco Rodríguez, Gloria Velasco, Carlos López-Otín. Matriptase-2 deficiency protects from obesity by modulating iron homeostasisNature Communications 2018; 9(1) doi: 10.1038/s41467-018-03853-1
16
I. Yu. Torshin, O. A. Gromova, T. E. Bogacheva. Systematic analysis of the relationship between non-alcoholic fatty liver disease and tissue iron overload: promising areas for the use of polypeptide therapyExperimental and Clinical Gastroenterology 2024; (10): 139 doi: 10.31146/1682-8658-ecg-218-10-139-152